Company Filing History:
Years Active: 1993
Title: The Innovative Contributions of Alison H. Goodall in the Field of Hepatitis B Research
Introduction: Alison H. Goodall, an accomplished inventor based in Buntingford, Great Britain, has made significant strides in the field of biomedical research. Renowned for her innovative work on monoclonal antibodies, she has secured a patent that holds tremendous potential for therapeutic applications against hepatitis B virus infections.
Latest Patents: Alison's notable patent pertains to the development of monoclonal antibodies against the hepatitis B virus. Specifically, her work involves the creation of new hybridoma cell lines, designated as RF-HBs-1, RF-HBs-2, and RF-HBs-4. Each of these cell lines secretes a unique monoclonal antibody that targets the hepatitis B surface antigen. The production of these antibodies can be performed in vitro by culturing the cell lines or in vivo through the establishment of an ascites tumor in mice to isolate antibodies from ascites fluid or serum. The therapeutic, preventative, and diagnostic implications of these antibodies are vast, making them particularly valuable for the purification of the hepatitis B surface antigen and in radiometric assay techniques that employ specific antibody combinations.
Career Highlights: Alison H. Goodall is currently affiliated with the National Research Development Corporation, where she has continued her pioneering work in scientific research and innovation. Her patent embodies her dedication to advancing medical science and improving public health outcomes associated with hepatitis B.
Collaborations: Throughout her career, Alison has collaborated with esteemed colleagues in her field, including George Janossy and Howard Christopher Thomas. These collaborations have not only enriched her research but have also demonstrated the importance of teamwork in scientific innovation.
Conclusion: Alison H. Goodall’s contributions to the development of monoclonal antibodies against the hepatitis B virus highlight her role as a vital innovator in biomedical research. Her patented work represents a hopeful advancement in the fight against hepatitis B, showcasing the impact that dedicated inventors can have on global health. The legacy of her innovations continues to inspire those in the scientific community.